Generic Drugs Access Act of 1999
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 23, 1999)
Generic Drugs Access Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act with respect to new drug applications to direct the Secretary of Health and Human Services to include in an application approval a finding about whether the approved (generic) drug is the therapeutic equivalent of the listed drug involved.
Prohibits a State or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.
What just happenedMar 11, 1999
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseFeb 23, 1999
- Mar 11, 1999CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Feb 23, 1999IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Feb 23, 1999IntroReferralB00100
Sponsor introductory remarks on measure. (CR E263)
- Feb 23, 1999IntroReferralIntro-H
Introduced in House
- Feb 23, 1999IntroReferral1000
Introduced in House